When will Clindamycin Phosphate Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Clindamycin Phosphate Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Clindamycin Phosphate Injection

Brand names: Cleocin Phosphate, Clindamycin In 5 Percent Dextrose, Clindamycin Phosphate

Category: Anti-Infective

Unavailable 3Limited 3Available 10Not specified 4

FDA status: Current, To Be Discontinued · Last FDA update: Sep 21, 2026 · First posted: Mar 21, 2023 (in shortage 3 years 6 months) · 4 manufacturers, 20 listed presentations

As of Sep 21, 2026, the FDA lists Clindamycin Phosphate Injection as being discontinued. Of 20 manufacturer presentations, 3 Unavailable, 3 Limited, 10 Available, 4 Not specified.

Ask your pharmacist: which of the 4 manufacturers below can they order right now, and whether a different strength or form of Clindamycin Phosphate Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09) NDC 0781-3288-09	Sandoz Inc.	Available	-
Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24) NDC 72572-074-24	Sandoz Inc.	Available	Civica Label
Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09) NDC 0781-3289-09	Sandoz Inc.	Available	-
Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24) NDC 72572-076-24	Sandoz Inc.	Available	Civica Label
Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09) NDC 0781-3290-09	Sandoz Inc.	Available	-
Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04) NDC 25021-115-04	Sagent Pharmaceuticals	Unavailable	Discontinuation of the manufacture of the drug
Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02) NDC 25021-115-02	Sagent Pharmaceuticals	Limited	Selling through remaining short-dated inventory (Dec 2026).
Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) NDC 25021-115-06	Sagent Pharmaceuticals	Limited	Selling through remaining short-dated inventory (Dec 2026).
Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50) NDC 0338-9545-50	Baxter Healthcare	Available	-
Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50) NDC 0338-9549-50	Baxter Healthcare	Available	-
Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50) NDC 0338-3410-50	Baxter Healthcare	Available	-
Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50) NDC 0338-3612-50	Baxter Healthcare	Unavailable	Estimated recovery: October 2026
Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50) NDC 0338-3814-50	Baxter Healthcare	Limited	Estimated recovery: November 2026
Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50) NDC 0338-9553-50	Baxter Healthcare	Available	-
Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02) NDC 0009-3051-02	Pfizer Inc.	Not specified	Discontinuation of the manufacture of the drug
Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04) NDC 0009-4073-04	Pfizer Inc.	Not specified	Discontinuation of the manufacture of the drug
Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18) NDC 0009-0902-18	Pfizer Inc.	Not specified	Discontinuation of the manufacture of the drug
Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06) NDC 0009-5095-06	Pfizer Inc.	Not specified	Discontinuation of the manufacture of the drug
Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26) NDC 0009-0870-26	Pfizer Inc.	Unavailable	Next Delivery and Estimated Recovery: December 2028
Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26) NDC 0009-0775-26	Pfizer Inc.	Available	-

Related medications in shortage

Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Clindamycin Phosphate Injection (FDA data as of Sep 21, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Clindamycin Phosphate Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Clindamycin Phosphate Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/clindamycin-phosphate-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).